Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

NCT00003336 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases

Interventions

BIOLOGICAL: anti-thymocyte globulin
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: melphalan
DRUG: methylprednisolone
PROCEDURE: bone marrow ablation with stem cell support
PROCEDURE: umbilical cord blood transplantation
RADIATION: radiation therapy

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]